"<p data-pm-slice=""1 1 []""><strong>Introduction</strong></p>
<p>Computational toxicology, an interdisciplinary science that leverages computational methods and information technology to assess chemical safety, is experiencing significant growth. This field combines toxicology, bioinformatics, machine learning, and molecular modeling to predict the toxic effects of chemical compounds, ultimately aiding regulatory agencies and industries in safer and faster decision-making processes. As the demand for faster, cost-effective, and ethically responsible testing methods increases, computational toxicology has become a vital tool in pharmaceuticals, agrochemicals, cosmetics, and environmental health sciences.</p>
<p>The global computational toxicology market is rapidly expanding, propelled by technological advancements and increasing regulatory pressures. According to recent market analysis, the sector is projected to grow at a Compound Annual Growth Rate (CAGR) of 12.5% from 2023 to 2030. In 2024, the combined revenue of leading companies surpassed USD 1.2 billion, indicating robust commercial interest and investment in this innovative field.</p>
<p>This article explores the key players in computational toxicology technology, analyzing their contributions, market performance, and innovations.</p>
<p><strong>To Learn more about this Report, Request Free Sample PDF @&nbsp;<a href=""https://www.globalmarketstatistics.com/market-reports/computational-toxicology-technology-market-13643"">https://www.globalmarketstatistics.com/market-reports/computational-toxicology-technology-market-13643</a></strong></p>
<div>&nbsp;</div>
<p><strong>1. Instem (Leadscope Inc)</strong></p>
<p><strong>Headquarters:</strong> Stone, Staffordshire, United Kingdom<br /><strong>CAGR (2023-2030):</strong> 11.7%<br /><strong>2024 Revenue:</strong> USD 95 million</p>
<p>Instem, through its acquisition of Leadscope Inc, has established itself as a frontrunner in computational toxicology. The company offers predictive toxicology software that enables researchers to assess the potential risks of chemical substances. Leadscope's QSAR (Quantitative Structure-Activity Relationship) models are used extensively by pharmaceutical firms and regulatory bodies like the FDA for non-animal toxicity assessments. Instem's integrated solutions support decision-making from discovery through regulatory submission.</p>
<div>&nbsp;</div>
<p><strong>2. Lhasa Limited</strong></p>
<p><strong>Headquarters:</strong> Leeds, United Kingdom<br /><strong>CAGR (2023-2030):</strong> 13.2%<br /><strong>2024 Revenue:</strong> USD 85 million</p>
<p>Lhasa Limited is a not-for-profit organization that develops software to support chemical risk assessment and toxicological evaluation. Its flagship products include Derek Nexus for toxicity prediction and Vitic for curated toxicological data. Lhasa is known for fostering collaboration across the chemical, pharmaceutical, and regulatory communities, contributing to the global knowledge base on toxicological science.</p>
<div>&nbsp;</div>
<p><strong>3. MultiCASE Inc</strong></p>
<p><strong>Headquarters:</strong> Beachwood, Ohio, USA<br /><strong>CAGR (2023-2030):</strong> 10.8%<br /><strong>2024 Revenue:</strong> USD 60 million</p>
<p>MultiCASE is a pioneer in developing statistical and artificial intelligence-based predictive toxicology software. Their CASE Ultra platform supports structure-activity relationship modeling and risk assessment. MultiCASE is widely used by regulatory agencies and industries for screening and prioritizing chemicals, ensuring safety and compliance with minimal animal testing.</p>
<div>&nbsp;</div>
<p><strong>4. Inotiv</strong></p>
<p><strong>Headquarters:</strong> West Lafayette, Indiana, USA<br /><strong>CAGR (2023-2030):</strong> 14.1%<br /><strong>2024 Revenue:</strong> USD 180 million</p>
<p>Inotiv provides drug discovery and development solutions, including advanced computational toxicology capabilities. Through its acquisition of various AI-focused companies, Inotiv has bolstered its in silico toxicology portfolio. It combines traditional toxicology methods with predictive modeling and machine learning to streamline preclinical research and reduce time-to-market.</p>
<p><strong>To Learn more about this Report, Request Free Sample PDF @&nbsp;<a href=""https://www.globalmarketstatistics.com/market-reports/computational-toxicology-technology-market-13643"">https://www.globalmarketstatistics.com/market-reports/computational-toxicology-technology-market-13643</a></strong></p>
<div>&nbsp;</div>
<p><strong>5. Simulations Plus</strong></p>
<p><strong>Headquarters:</strong> Lancaster, California, USA<br /><strong>CAGR (2023-2030):</strong> 13.5%<br /><strong>2024 Revenue:</strong> USD 65 million</p>
<p>Simulations Plus specializes in modeling and simulation software for pharmaceutical research, with a growing emphasis on toxicology. Their ADMET Predictor and GastroPlus tools help predict the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of drug candidates. The company plays a significant role in virtual drug screening and computational risk analysis.</p>
<div>&nbsp;</div>
<p><strong>6. Schr&ouml;dinger, Inc.</strong></p>
<p><strong>Headquarters:</strong> New York, New York, USA<br /><strong>CAGR (2023-2030):</strong> 15.6%<br /><strong>2024 Revenue:</strong> USD 180 million</p>
<p>Schr&ouml;dinger is renowned for its physics-based computational platform that enhances drug discovery and materials design. Its integrated platform incorporates molecular dynamics and quantum mechanics to predict toxicity and efficacy with high precision. The company collaborates with numerous pharmaceutical giants, demonstrating the value of computational tools in early-stage toxicology.</p>
<div>&nbsp;</div>
<p><strong>7. Aclaris Therapeutics</strong></p>
<p><strong>Headquarters:</strong> Wayne, Pennsylvania, USA<br /><strong>CAGR (2023-2030):</strong> 9.7%<br /><strong>2024 Revenue:</strong> USD 45 million</p>
<p>While primarily known as a biopharmaceutical company, Aclaris has invested in computational platforms to support its R&amp;D pipeline. Its focus includes predictive analytics and machine learning to evaluate compound safety and efficacy, particularly for inflammatory and dermatological conditions.</p>
<div>&nbsp;</div>
<p><strong>8. Evogene Ltd.</strong></p>
<p><strong>Headquarters:</strong> Rehovot, Israel<br /><strong>CAGR (2023-2030):</strong> 12.3%<br /><strong>2024 Revenue:</strong> USD 50 million</p>
<p>Evogene applies computational biology to the development of life-science products in human health, agriculture, and industrial sectors. Through its predictive biology platform, Evogene leverages big data and AI to identify and design safer, more effective compounds with lower toxicological risk.</p>
<p><strong>To Learn more about this Report, Request Free Sample PDF @&nbsp;<a href=""https://www.globalmarketstatistics.com/market-reports/computational-toxicology-technology-market-13643"">https://www.globalmarketstatistics.com/market-reports/computational-toxicology-technology-market-13643</a></strong></p>
<div>&nbsp;</div>
<p><strong>9. Deciphex (Patholytix)</strong></p>
<p><strong>Headquarters:</strong> Dublin, Ireland<br /><strong>CAGR (2023-2030):</strong> 16.2%<br /><strong>2024 Revenue:</strong> USD 40 million</p>
<p>Deciphex is revolutionizing toxicologic pathology with its Patholytix preclinical platform. By integrating AI and digital pathology, the company offers advanced solutions for toxicological assessments. Their technology supports efficient data review and reporting, accelerating toxicology workflows.</p>
<div>&nbsp;</div>
<p><strong>10. Exscientia</strong></p>
<p><strong>Headquarters:</strong> Oxford, United Kingdom<br /><strong>CAGR (2023-2030):</strong> 17.5%<br /><strong>2024 Revenue:</strong> USD 140 million</p>
<p>Exscientia is a global leader in AI-driven drug discovery, combining deep learning and knowledge-based models for target identification and toxicity prediction. Their proprietary platform integrates patient data, chemistry, and toxicology to optimize compound selection, making drug development faster and safer.</p>
<div>&nbsp;</div>
<p><strong>Conclusion</strong></p>
<p>The computational toxicology market is undergoing a transformative evolution. Innovations in AI, machine learning, and high-performance computing are empowering companies to predict toxicological outcomes with unprecedented accuracy. The ten companies featured in this article are at the forefront of this shift, offering robust platforms that blend science, technology, and data analytics.</p>
<p>As regulatory expectations increase and the demand for animal-free testing intensifies, computational toxicology is poised to become a cornerstone of modern safety assessment across multiple industries. These companies are not only shaping the future of drug and chemical safety but also paving the way for more ethical, efficient, and intelligent R&amp;D processes.</p>
<p><strong>To Learn more about this Report, Request Free Sample PDF @&nbsp;<a href=""https://www.globalmarketstatistics.com/market-reports/computational-toxicology-technology-market-13643"">https://www.globalmarketstatistics.com/market-reports/computational-toxicology-technology-market-13643</a></strong></p>"
